what glp-1 is approved for sleep apnea Did You Know? The FDA has approved GLP-1 treatments for moderate to severe obstructive sleep apnea (OSA) in adults with obesity. This breakthrough provides a new GLP-1 Medications and Sleep Apnea:

GLP-1 therapy has been linked to improved inflammatory markers (like Hs-CRP), metabolic markers (like HbA1C), and lipid/cholesterol markers (like HDL and LDL)

Nature Medicine 2024: s41591-024-03018-2 48-week MRI-PDFF liver fat reduction (51% at 1 mg, 86% at 12 mg)

Br J Clin Pharmacol 2025 demonstrates that co-infusing a GLP-1 agonist with glucagon produces a perfectly additive HR response (+4 bpm + +4 bpm = +7 bpm at 60 min in n=12 lean males), confirming that glucagon drives chronotropy via a parallel pathway independent of GLP-1R cross-reactivity

Storage: Long-term To maintain stability and product integrity, peptides go through lyophilization